한글목차

헬리코박터 파일로리 진단 동향 및 전망

세계 헬리코박터 파일로리 진단 시장의 미래는 병원, 진단 연구소, 클리닉 시장에서의 기회로 인해 유망합니다. 세계 헬리코박터 파일로리 진단 시장은 2024년부터 2030년까지 연평균 4.8%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 개별 항생제 치료에 대한 수요 증가, 감염성 질환의 증가, 감염성 질환에 대한 지식 증가, 헬리코박터 파일로리 감염 검출의 비용 효율성 향상 등입니다.

• Lucintel은 유형별로는 새로운 기술 발전이 필요한 위 질환의 발생이 증가함에 따라 시약이 예측 기간 동안 가장 큰 부문을 차지할 것으로 예상하고 있습니다.
• 이 시장에서 병원은 십이지장 궤양, 위암, 위염, 위궤양과 같은 질병의 발생률 증가로 인해 최종 사용 범주에서 가장 큰 부문을 차지할 것으로 보입니다.
• 지역별로는 북미가 의료 인프라 구축, FDA, NIH, CDC 등 기관의 조치, 신흥 경제국의 존재로 인해 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

헬리코박터 파일로리 진단 시장에서의 전략적 성장 기회

헬리코박터 파일로리 진단 시장은 치료되지 않은 감염으로 인한 건강 위험에 대한 인식이 높아지고 첨단 진단 기술의 가용성이 향상됨에 따라 큰 성장 기회를 제공하고 있습니다. 전 세계 의료 시스템이 위 질환의 조기 발견과 예방에 우선순위를 두고 있는 가운데, 이 성장 시장에서 기업들은 제품 공급을 확대할 수 있는 큰 잠재력을 가지고 있습니다. 신흥 기술을 활용하고 새로운 지역으로 진출함으로써, 기업들은 그동안 제대로 서비스를 제공받지 못했던 시장을 개척하고 환자들의 예후를 개선할 수 있습니다.

• 비침습적 진단의 확대 : 호흡 검사, 대변 항원 검사 등 비침습적 진단 방법의 개발 및 판매에 주력하는 기업들은 비침습적 진단 방법의 인기 상승에 편승할 수 있습니다.
• 신흥시장 : 의료 인프라가 개선되고 있고 위 질환의 부담이 여전히 큰 아시아, 아프리카, 라틴아메리카의 신흥시장은 사업 확장의 큰 기회가 있습니다.
• 개별화 진단 및 치료 : 유전적 변이 및 항균제 내성 패턴을 고려한 진단을 포함한 개별화 의료의 움직임은 새로운 성장의 길을 제공합니다.
• 원격의료 및 디지털 건강과의 통합 : 진단 검사를 원격의료 플랫폼과 통합하여 특히 원격지 환자의 의료 접근성을 강화하여 진단 의약품 기업에 새로운 기회를 제공합니다.
• 의료기관과의 파트너십 : 종합적인 진단 및 치료 솔루션을 개발하기 위해 병원, 클리닉, 제약회사와의 전략적 파트너십을 통해 시장 성장을 촉진할 수 있습니다.

Helicobacter pylori 진단 시장의 전략적 성장 기회는 풍부하며, 특히 비침습적 진단 방법의 확대, 신흥 시장 공략, 맞춤형 의료의 통합에 집중하는 기업에게 중요합니다. 의료 서비스 제공자와의 제휴 및 원격의료 플랫폼의 활용은 시장 도달 범위와 환자 치료 접근성을 강화할 수 있습니다. 이러한 기회를 활용하면 기업은 빠르게 성장하는 헬리코박터 파일로리 진단 시장에서 선두주자로 자리매김할 수 있습니다.

헬리코박터 파일로리 진단 시장의 촉진요인 및 과제

헬리코박터 파일로리 진단 시장은 헬리코박터 파일로리 감염으로 인한 건강 위험에 대한 인식이 높아지고, 정확하고 비침습적인 진단 도구에 대한 수요가 증가하는 등 다양한 요인에 의해 영향을 받고 있습니다. 그러나 시장은 규제 장벽, 검사의 복잡성, 시장 경쟁과 같은 도전에 직면해 있습니다. 헬리코박터 파일로리 진단의 경쟁 환경과 진화에서 성공하기 위해서는 이해관계자들이 촉진요인과 도전 과제를 모두 이해하는 것이 필수적입니다.

시장 촉진요인:

• 위 질환 유병률 증가 : 헬리코박터 파일로리균 감염과 관련된 위궤양, 위염, 위암 발병률 증가가 진단 검사 수요를 견인하고 있습니다.
• 비침습적 검사로의 전환 : 호흡 항원 검사, 대변 항원 검사 등 비침습적 검사는 사용 편의성 및 환자 편의성 향상으로 많은 지지를 받고 있습니다.
• H. pylori 위험에 대한 인식 증가 : 위 질환에서 H. pylori의 역할에 대한 인식이 높아짐에 따라 조기 발견과 효과적인 치료에 대한 수요도 증가하고 있습니다.
• 진단 기술 발전 : PCR, 차세대 염기서열 분석 등 분자진단 분야의 지속적인 혁신으로 헬리코박터 파일로리균 검출이 더욱 빠르고 정확하며 최소침습적으로 이루어지고 있습니다.
• 의료 인프라 구축 : 신흥국 시장에서의 성장 기회 : 개발도상국의 의료 인프라 확충으로 진단 도구에 대한 접근성이 향상되고 있습니다.

시장의 과제

• 규제 장벽 : 새로운 진단 검사에 대한 규제 당국의 승인 절차가 복잡하고 시간이 오래 걸리기 때문에 혁신적인 솔루션이 시장에 출시되는 데 시간이 오래 걸립니다.
• 첨단 진단약의 비용 : 특히 저소득 지역이나 예산이 한정된 의료 환경에서는 첨단 진단 기술과 관련된 높은 비용이 보급을 제한할 수 있습니다.
• 진단 정확도 및 위양성 : 발전에도 불구하고 일부 진단 방법은 여전히 정확도에 문제가 있어 위양성 및 위음성을 유발하고 환자 관리를 복잡하게 만들 수 있습니다.

HIV 진단 시장은 조기 발견에 대한 수요 증가, 비침습적 검사로의 전환, 진단 기술의 발전에 힘입어 성장하고 있습니다. 그러나 규제 장벽, 비용, 다른 검사법과의 경쟁 등 여러 가지 도전과제가 남아있습니다. 이러한 도전과제를 해결하고 주요 시장 촉진요인을 활용하면 기업은 변화하는 상황을 극복하고 이 중요한 위장 건강 분야에서 성장 기회를 포착할 수 있습니다.

목차

제1장 주요 요약

제2장 세계의 헬리코박터 파일로리 진단 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 헬리코박터 파일로리 진단 시장 동향(2018-2023년)과 예측(2024-2030년)
• 헬리코박터 파일로리 진단 시장 : 유형별
  • 기기
  • 시약
  • 서비스
• 헬리코박터 파일로리 진단 세계 시장 : 기술별
  • 면역측정
  • POC 검사
  • 분자진단
• 헬리코박터 파일로리 진단 시장 세계 규모 : 최종 용도별
  • 병원
  • 진단 연구소
  • 클리닉

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 헬리코박터 파일로리 진단 시장
• 북미의 헬리코박터 파일로리 진단 시장
• 유럽의 헬리코박터 파일로리 진단 시장
• 아시아태평양의 헬리코박터 파일로리 진단 시장
• 기타 지역의 헬리코박터 파일로리 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 헬리코박터 파일로리 진단 시장 유형별 성장 기회
  • 세계의 헬리코박터 파일로리 진단 시장 기술별 성장 기회
  • 세계의 헬리코박터 파일로리 진단 시장 최종 용도별 성장 기회
  • 세계의 헬리코박터 파일로리 진단 시장 지역별 성장 기회
• 세계의 헬리코박터 파일로리 진단 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 헬리코박터 파일로리 진단 시장 능력 확대
  • 세계의 헬리코박터 파일로리 진단 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Thermo Fisher Scientific
• Biohit
• Quest Diagnostics
• Meridian Bioscience
• Bio-Rad Laboratories
• Alpha Laboratories
• F. Hoffmann-La Roche
• Coris BioConcept
• Certest Biotec
• Epitope Diagnostics

영문목차

Helicobacter Pylori Diagnostic Trends and Forecast

The future of the global helicobacter pylori diagnostic market looks promising with opportunities in the hospital, diagnostic laboratory, and clinic markets. The global helicobacter pylori diagnostic market is expected to grow with a CAGR of 4.8% from 2024 to 2030. The major drivers for this market are the growing need for individualized antibiotic treatment, the increase of infectious illnesses, as well as, rising knowledge of infections and enhanced cost-effectiveness of helicobacter pylori infection detection.

• Lucintel forecasts that, within the type category, reagents will remain the largest segment over the forecast period due to increasing occurrences of gastric diseases necessitating new technological advancements.
• Within this market, within the end-use category, hospitals will remain the largest segment due to the increasing incidence of conditions like duodenal ulcers, stomach cancer, gastritis, and gastric ulcers.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the creation of the healthcare infrastructure, actions taken by agencies like the FDA, NIH, and CDC, and the existence of developed economies.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Helicobacter Pylori Diagnostic Market

The Helicobacter pylori (H. pylori) diagnostic market has been experiencing significant transformations due to new technologies, improved diagnostic methods, and evolving healthcare needs. With H. pylori being a major cause of gastric ulcers and a key risk factor for gastric cancer, the demand for rapid, accurate, and non-invasive diagnostic tools continues to rise. Emerging trends in this field focus on enhancing test accuracy, speed, and patient convenience, while also reducing costs and improving accessibility to diagnostics in underserved regions.

• Advancements in Non-Invasive Testing: There is a growing adoption of non-invasive testing methods such as breath tests and stool antigen tests, which provide quicker and more comfortable alternatives to invasive biopsy procedures.
• Integration of Point-of-Care (POC) Testing: The development of portable, easy-to-use POC diagnostic devices is making H. pylori testing more accessible, especially in remote or rural areas.
• Rise of Molecular Diagnostics: Molecular techniques, such as PCR-based tests, are gaining popularity for their high sensitivity and accuracy in detecting H. pylori, particularly in complex or hard-to-diagnose cases.
• Focus on Personalized Medicine: Tailoring diagnostic tests to individual patient's needs, such as genetic susceptibility and antimicrobial resistance patterns, is becoming a key trend in H. pylori diagnostics.
• Increasing Use of Artificial Intelligence (AI): AI and machine learning algorithms are being integrated into diagnostic platforms to improve the speed and accuracy of H. pylori detection and interpretation of results.

Emerging trends in the H. pylori diagnostic market indicate a shift toward non-invasive, rapid, and highly accurate diagnostic methods, with a strong focus on accessibility and cost-effectiveness. Advances in molecular diagnostics, point-of-care devices, and AI integration will drive the next generation of H. pylori diagnostic tools. These innovations are set to significantly improve patient outcomes and expand the availability of diagnostic services globally, particularly in underserved regions.

Recent Developments in the Helicobacter Pylori Diagnostic Market

Recent developments in the Helicobacter pylori diagnostic market reflect a growing emphasis on improving the accuracy, speed, and patient experience in detecting H. pylori infections. Advances in testing technology, along with the increasing recognition of the link between H. pylori and various gastric diseases, are driving growth in the diagnostic sector. This section highlights key innovations and trends that are shaping the future of H. pylori diagnosis.

• Introduction of Advanced Breath Tests: The development of more sophisticated and accurate breath tests, such as those using isotope-labeled carbon, has improved the non-invasive detection of H. pylori infection.
• Novel Stool Antigen Tests: New, more sensitive stool antigen tests are improving diagnostic accuracy and are now being adopted for both initial diagnosis and post-treatment monitoring of H. pylori infections.
• Increased Focus on Rapid Diagnostic Kits: The market has seen the emergence of rapid diagnostic kits that provide quick results, reducing the need for laboratory-based analysis and enhancing patient convenience.
• AI-Assisted Diagnostics: Machine learning algorithms are increasingly being applied to assist in interpreting diagnostic results, improving both the accuracy and speed of diagnosing H. pylori infections.
• Collaborations with Research Institutions: Strategic collaborations between diagnostic companies and research institutions are facilitating the development of next-generation diagnostic tools, including tests that can identify antimicrobial resistance in H. pylori strains.

Recent developments in the H. pylori diagnostic market are largely driven by advancements in non-invasive testing technologies, including breath and stool antigen tests, as well as the integration of AI and machine learning into diagnostic platforms. These innovations not only enhance diagnostic accuracy and speed but also improve the patient experience. As the demand for quick and reliable H. pylori testing grows, the market is likely to see continued progress in both technology and accessibility.

Strategic Growth Opportunities for Helicobacter Pylori Diagnostic Market

The helicobacter pylori diagnostic market presents significant growth opportunities, driven by rising awareness of the health risks associated with untreated infections and the increasing availability of advanced diagnostic technologies. As global healthcare systems prioritize early detection and prevention of gastric diseases, there is substantial potential for companies to expand their offerings in this growing market. By leveraging emerging technologies and expanding into new regions, companies can tap into previously underserved markets and improve patient outcomes.

• Expansion of Non-Invasive Diagnostics: Companies focusing on the development and distribution of non-invasive diagnostic methods, such as breath tests and stool antigen tests, can capitalize on their growing popularity.
• Emerging Markets: There is a strong opportunity for expansion into emerging markets in Asia, Africa, and Latin America, where healthcare infrastructure is improving and the burden of gastric diseases remains high.
• Personalized Diagnostics and Treatment: The move toward personalized medicine, including diagnostics that take into account genetic variations and antimicrobial resistance patterns, offers new avenues for growth.
• Integration with Telemedicine and Digital Health: Integrating diagnostic tests with telemedicine platforms can enhance patient access to care, especially in remote areas, and create new business opportunities for diagnostic companies.
• Partnerships with Healthcare Providers: Strategic partnerships with hospitals, clinics, and pharmaceutical companies to develop comprehensive diagnostic and treatment solutions can boost market growth.

Strategic growth opportunities in the H. pylori diagnostic market are abundant, particularly for companies that focus on expanding non-invasive diagnostics, targeting emerging markets, and integrating personalized medicine. Collaborations with healthcare providers and leveraging telemedicine platforms will also enhance market reach and patient access to care. By capitalizing on these opportunities, companies can position themselves as leaders in the rapidly growing H. pylori diagnostic market.

Helicobacter Pylori Diagnostic Market Driver and Challenges

The helicobacter pylori diagnostic market is influenced by various factors, including the growing recognition of the health risks posed by H. pylori infections and the increasing demand for accurate and non-invasive diagnostic tools. However, the market also faces challenges, such as regulatory hurdles, the complexity of testing, and market competition. Understanding both the drivers and challenges is essential for stakeholders aiming to succeed in the competitive and evolving landscape of H. pylori diagnostics.

Market Drivers:

• Increased Prevalence of Gastric Diseases: The rising incidence of gastric ulcers, gastritis, and gastric cancer linked to H. pylori infections is driving the demand for diagnostic testing.
• Shift Toward Non-Invasive Testing: Non-invasive tests, such as breath and stool antigen tests, are gaining traction due to their ease of use and improved patient comfort.
• Growing Awareness of H. pylori Risks: As awareness about the role of H. pylori in gastric diseases increases, so does the demand for early detection and effective treatment.
• Technological Advancements in Diagnostics: Ongoing innovations in molecular diagnostics, such as PCR and next-generation sequencing, are making H. pylori detection faster, more accurate, and less invasive.
• Healthcare Infrastructure Development: Expanding healthcare infrastructure in developing regions is increasing access to diagnostic tools, creating growth opportunities in underserved markets.

Market Challenges:

• Regulatory Barriers: Regulatory approval processes for new diagnostic tests can be complex and time-consuming, slowing the time to market for innovative solutions.
• Cost of Advanced Diagnostics: High costs associated with advanced diagnostic technologies may limit adoption, particularly in low-income regions or healthcare settings with limited budgets.
• Diagnosis Accuracy and False Positives: Despite advances, some diagnostic methods still struggle with accuracy, leading to false positives or false negatives, which can complicate patient management.

The H. pylori diagnostic market is driven by increasing demand for early detection, the shift toward non-invasive testing, and advancements in diagnostic technology. However, challenges such as regulatory hurdles, cost considerations, and competition from other testing methods remain. By addressing these challenges and capitalizing on key market drivers, companies can navigate the evolving landscape and seize opportunities for growth in this important area of gastrointestinal health.

List of Helicobacter Pylori Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies helicobacter pylori diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the helicobacter pylori diagnostic companies profiled in this report include-

• Thermo Fisher Scientific
• Biohit
• Quest Diagnostics
• Meridian Bioscience
• Bio-Rad Laboratories
• Alpha Laboratories
• F. Hoffmann-La Roche
• Coris BioConcept
• Certest Biotec
• Epitope Diagnostics

Helicobacter Pylori Diagnostic by Segment

The study includes a forecast for the global helicobacter pylori diagnostic by type, technology, end use, and region.

Helicobacter Pylori Diagnostic Market by Type [Analysis by Value from 2018 to 2030]:

• Instruments
• Reagents
• Services

Helicobacter Pylori Diagnostic Market by Technology [Analysis by Value from 2018 to 2030]:

• Immunoassays
• POC
• Molecular Diagnostics

Helicobacter Pylori Diagnostic Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostics Laboratories
• Clinics

Helicobacter Pylori Diagnostic Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Helicobacter Pylori Diagnostic Market

In recent years, the Helicobacter pylori (H. pylori) diagnostic market has been growing rapidly, driven by increasing awareness of gastrointestinal problems and the rising incidence of H. pylori-related conditions globally. Diagnostic innovations, particularly non-invasive tests and molecular diagnostics, have significantly improved the ease of detection and increased the rate of identification of this bacterium. The market's expansion is also supported by regulatory approvals of new diagnostic devices and increased collaboration among industry players. Regions such as the USA, China, Germany, India, and Japan are at the forefront of these trends, focusing on improving health indicators through advanced diagnostics.

• United States: The U.S. market has seen a breakthrough in H. pylori diagnostics with the introduction of non-invasive methods, especially polymerase chain reaction (PCR)-based techniques that target specific gene sequences to detect the presence of H. pylori DNA in bronchoalveolar lavage fluid (BALF). Breath and stool antigen tests have gained popularity due to their fast turnaround times, which enhance patient satisfaction. Additionally, new trends in biomolecular diagnostic techniques have led to clearer and more accurate diagnostic criteria. Future market growth is expected to be driven by approvals for advanced diagnostic kits, as well as collaborations between diagnostic manufacturers and healthcare providers to improve screening practices.
• China: The H. pylori diagnostic market in China is growing rapidly, thanks to increasing health consciousness and improved healthcare facilities. The market also forecasts a rising demand for portable and efficient cellular infectious disease testing kits. The Chinese government supports gastrointestinal disorder prevention programs, which further boosts market growth. Companies like Nogoer are focusing on the development of rapidly marketable and functional diagnostic solutions tailored to the population's needs.
• Germany: Although competition in Germany for H. pylori diagnostic tests is intense, it has not deterred customers from making substantial investments, as the country remains a leader in adopting new diagnostic technologies. More physicians are incorporating rapid tests and advanced molecular diagnostic kits into their practices. Germany's market is highly regulated, meaning only the most reliable and rugged diagnostic tools are approved for use. High priority is placed on research into novel diagnostic methods through collaborations between universities and biopharmaceutical firms, which helps promote better detection and treatment of patients.
• India: The H. pylori diagnostic market in India is booming due to the rising incidence of gastrointestinal disorders. Growing investments in healthcare facilities are facilitating the adoption of newer technologies, such as rapid antigen tests and molecular diagnostics. These solutions must remain affordable to accommodate the diverse patient population. Additionally, government initiatives aimed at improving the understanding of H. pylori as a disease are enabling earlier diagnoses and treatments, thereby expanding the scope of the market.
• Japan: The H. pylori diagnostic market in Japan is highly competitive, with a strong focus on technology and research and development (R&D). The introduction of new technologies, such as breath tests, aims to enhance patient comfort without compromising diagnostic accuracy. Japanese manufacturers are developing next-generation diagnostic kits with more functionalities and ease of use. Collaborations with universities and research institutions play a key role in addressing the challenges of H. pylori populations as part of the broader national health strategy.

Features of the Global Helicobacter Pylori Diagnostic Market

Market Size Estimates: Helicobacter pylori diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Helicobacter pylori diagnostic market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: Helicobacter pylori diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, technology, end use, and regions for the helicobacter pylori diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the helicobacter pylori diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the helicobacter pylori diagnostic market by type (instruments, reagents, and services), technology (immunoassays, POC, and molecular diagnostics), end use (hospitals, diagnostics laboratories, and clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Helicobacter Pylori Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Helicobacter Pylori Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Helicobacter Pylori Diagnostic Market by Type
  • 3.3.1: Instruments
  • 3.3.2: Reagents
  • 3.3.3: Services
• 3.4: Global Helicobacter Pylori Diagnostic Market by Technology
  • 3.4.1: Immunoassays
  • 3.4.2: POC
  • 3.4.3: Molecular Diagnostics
• 3.5: Global Helicobacter Pylori Diagnostic Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostics Laboratories
  • 3.5.3: Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Helicobacter Pylori Diagnostic Market by Region
• 4.2: North American Helicobacter Pylori Diagnostic Market
  • 4.2.1: North American Market by Type: Instruments, Reagents, and Services
  • 4.2.2: North American Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.3: European Helicobacter Pylori Diagnostic Market
  • 4.3.1: European Market by Type: Instruments, Reagents, and Services
  • 4.3.2: European Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.4: APAC Helicobacter Pylori Diagnostic Market
  • 4.4.1: APAC Market by Type: Instruments, Reagents, and Services
  • 4.4.2: APAC Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.5: ROW Helicobacter Pylori Diagnostic Market
  • 4.5.1: ROW Market by Type: Instruments, Reagents, and Services
  • 4.5.2: ROW Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Type
  • 6.1.2: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by End Use
  • 6.1.4: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Helicobacter Pylori Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Helicobacter Pylori Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Helicobacter Pylori Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Biohit
• 7.3: Quest Diagnostics
• 7.4: Meridian Bioscience
• 7.5: Bio-Rad Laboratories
• 7.6: Alpha Laboratories
• 7.7: F. Hoffmann-La Roche
• 7.8: Coris BioConcept
• 7.9: Certest Biotec
• 7.10: Epitope Diagnostics